Clifutinib is an investigational new drug that is being developed by Sunshine Lake Pharma Co., Ltd. for the treatment of acute myeloid leukaemia (AML). It is a fms related receptor tyrosine kinase 3 (FLT3) inhibitor.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.